Literature DB >> 24748332

Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study.

Teruki Miyake1, Teru Kumagi, Masashi Hirooka, Shinya Furukawa, Keitarou Kawasaki, Mitsuhito Koizumi, Yasuhiko Todo, Shin Yamamoto, Hiroaki Nunoi, Yoshio Tokumoto, Yoshio Ikeda, Masanori Abe, Kohichiro Kitai, Bunzo Matsuura, Yoichi Hiasa.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a risk factor for diabetes and cardiovascular disease that could progress to nonalcoholic steatohepatitis, cirrhosis, and liver failure. We aimed to assess the relationship between NAFLD and lifestyle habits.
METHODS: Using a community-based, cross-sectional design, the records of 11,094 Japanese subjects who had undergone at least 1 annual health checkup were reviewed.
RESULTS: Of the 6,370 subjects who qualified for enrolment, 1,346 met the diagnostic criteria for NAFLD. The prevalence rate (PR) of NAFLD increased significantly to 36.6, 41.5, and 41.1 % with no snacking, snacking less than once/day, and snacking ≥2 times/day, respectively, in men (P = 0.0495) and to 10.8, 11.7, and 15.3 %, respectively, in women (P = 0.002). In men, the NAFLD PR decreased significantly to 48.8, 36.9, and 29.9 % with no exercise, exercise consciousness, and periodical exercise, respectively (P < 0.001). In women, the NAFLD PR decreased significantly to 19.3, 13.5, 11, and 8 % with sleep durations of ≤4, 5-6, 7-8, and ≥9 h, respectively (P = 0.003). Periodical exercise was identified as an independent factor associated with NAFLD in men (odds ratio 0.707, 95 % confidence interval 0.546-0.914; P = 0.008).
CONCLUSIONS: Performing regular exercise was associated with a reduced risk for NAFLD in men. Men with a high risk for NAFLD can be identified using questionnaires on exercise in an outpatient setting. Disease progression and further complications may be prevented by educating high-risk NAFLD patients about the importance of exercise.

Entities:  

Mesh:

Year:  2014        PMID: 24748332     DOI: 10.1007/s00535-014-0959-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  28 in total

Review 1.  Oestrogen's regulation of fat metabolism during exercise and gender specific effects.

Authors:  Tanja Oosthuyse; Andrew N Bosch
Journal:  Curr Opin Pharmacol       Date:  2012-03-05       Impact factor: 5.547

Review 2.  Non-alcoholic fatty liver disease: factors associated with its presence and onset.

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Yoshio Tokumoto; Masashi Hirooka; Masanori Abe; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol Hepatol       Date:  2013-12       Impact factor: 4.029

3.  The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.

Authors:  Lei Shi; Zhong Wu Liu; Yun Li; Cai Gong; Huan Zhang; Li Juan Song; Cheng Yu Huang; Ming Li
Journal:  Biomed Environ Sci       Date:  2012-08       Impact factor: 3.118

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Mitsuhito Koizumi; Yoshio Tokumoto; Teruhisa Ueda; Shin Yamamoto; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-08-31       Impact factor: 7.527

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 7.  Non-exercise activity thermogenesis (NEAT).

Authors:  James A Levine
Journal:  Nutr Rev       Date:  2004-07       Impact factor: 7.110

8.  Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography.

Authors:  Maki Tobari; Etsuko Hashimoto; Satoru Yatsuji; Nobuyuki Torii; Keiko Shiratori
Journal:  Intern Med       Date:  2009-05-15       Impact factor: 1.271

9.  Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study.

Authors:  Shira Zelber-Sagi; Dorit Nitzan-Kaluski; Rebecca Goldsmith; Muriel Webb; Laurie Blendis; Zamir Halpern; Ran Oren
Journal:  J Hepatol       Date:  2007-08-14       Impact factor: 25.083

10.  Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults.

Authors:  Ji Cheol Bae; Sunghwan Suh; Se Eun Park; Eun Jung Rhee; Cheol Young Park; Ki Won Oh; Sung Woo Park; Sun Woo Kim; Kyu Yeon Hur; Jae Hyeon Kim; Myung-Shik Lee; Moon Kyu Lee; Kwang-Won Kim; Won-Young Lee
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

View more
  10 in total

1.  Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease.

Authors:  James Philip Esteban; Amreen Dinani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-03

2.  Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Masashi Hirooka; Keitarou Kawasaki; Mitsuhito Koizumi; Yasuhiko Todo; Shin Yamamoto; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2014-08-13       Impact factor: 7.527

Review 3.  Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.

Authors:  Akshay Shetty; Jennifer W Hsu; Paul P Manka; Wing-Kin Syn
Journal:  Dig Dis Sci       Date:  2018-08-18       Impact factor: 3.199

Review 4.  Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review.

Authors:  Yoshihiro Kamada; Hirokazu Takahashi; Masahito Shimizu; Takumi Kawaguchi; Yoshio Sumida; Hideki Fujii; Yuya Seko; Shinya Fukunishi; Katsutoshi Tokushige; Atsushi Nakajima; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2021-10-31       Impact factor: 7.527

Review 5.  Oxidative stress in obesity: a critical component in human diseases.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Antonio Nicotera; Eleonora Parisi; Gabriella Di Rosa; Eloisa Gitto; Teresa Arrigo
Journal:  Int J Mol Sci       Date:  2014-12-26       Impact factor: 5.923

6.  Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Shanhu Qiu; Xue Cai; Zilin Sun; Ling Li; Martina Zügel; Jürgen Michael Steinacker; Uwe Schumann
Journal:  Therap Adv Gastroenterol       Date:  2017-08-25       Impact factor: 4.409

7.  Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials.

Authors:  Daniel Pfirrmann; Nils Haller; Yvonne Huber; Patrick Jung; Klaus Lieb; Ines Gockel; Krystyna Poplawska; Jörn Markus Schattenberg; Perikles Simon
Journal:  JMIR Res Protoc       Date:  2018-05-22

8.  A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population.

Authors:  Narumi Muto; Kentaro Oniki; Miku Kudo; Yui Obata; Yuki Sakamoto; Naoto Tokumaru; Tomoko Izuka; Takehisa Watanabe; Koji Otake; Yasuhiro Ogata; Junji Saruwatari
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-12       Impact factor: 3.168

9.  Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease.

Authors:  Ni Cui; Hui Li; Yaoshan Dun; Jeffrey W Ripley-Gonzalez; Baiyang You; Dezhao Li; Yuan Liu; Ling Qiu; Cui Li; Suixin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

Review 10.  Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  David Carneros; Guillermo López-Lluch; Matilde Bustos
Journal:  Nutrients       Date:  2020-11-12       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.